Silent thyroiditis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Mazia Fatima (talk | contribs) |
No edit summary |
||
| Line 18: | Line 18: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Primary care]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 15:19, 18 October 2017
|
Silent thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Silent thyroiditis medical therapy On the Web |
|
American Roentgen Ray Society Images of Silent thyroiditis medical therapy |
|
Risk calculators and risk factors for Silent thyroiditis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]
Overview
Pharmacologic medical therapies for silent thyroiditis include beta blockers for thyrotoxicosis symptoms and levothyroxine for the hypothyroidism if it follows the hyperthyroid state.
Medical Therapy
Silent thyroiditis
The drugs used in the treatment of silent thyroiditis are:[1][2][3]
- For thyrotoxic symptoms
- Preferred regimen (1): atenolol: 25-200mg per day orally
- Preferred regimen (2): metoprolol: 25-200mg per day orally
- For hypothyroidism
- Preferred regimen (1): Synthetic levothyroxine (L-T4): 1.6–1.8 μg/kg per day orally
References
- ↑ Samuels MH (2012). "Subacute, silent, and postpartum thyroiditis". Med. Clin. North Am. 96 (2): 223–33. doi:10.1016/j.mcna.2012.01.003. PMID 22443972.
- ↑ Schubert MF, Kountz DS (1995). "Thyroiditis. A disease with many faces". Postgrad Med. 98 (2): 101–3, 107–8, 112. PMID 7630839.
- ↑ Singer PA (1991). "Thyroiditis. Acute, subacute, and chronic". Med. Clin. North Am. 75 (1): 61–77. PMID 1987447.